VIE/ARGX (VIE/ARGX)

Vienna Stock Exchange: VIE/ARGX · EUR

€799

+22.20 (+2.9%)· Recorded snapshot

Market cap	49.8B
Revenue (ttm)	5.2B
Net income (ttm)	1.7B
EPS (ttm)	€25.4
P/E (trailing)	31.4x
P/E (forward)	25.8x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.2B
Net income (ttm): 1.7B
EPS (ttm): €25.4
P/E (trailing): 31.4x
P/E (forward): 25.8x
Market cap: 49.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E25.8

P25 n/aP50 n/aP75 n/a

Trailing P/E31.4

P25 n/aP50 n/aP75 n/a

ROE23.6

P25 n/aP50 n/aP75 n/a

ROIC57

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ARGX indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Netherlands
Country code	AT
Earnings date	2026-10-22
Employees	1,863
Employees change	451
Employees growth	39.29%
Enterprise value	EUR 45.3B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2008
Industry	Biotechnology
Is primary listing	No
ISIN number	NL0010832176
Last earnings date	2026-10-22
Last refreshed	2026-10-29
Market cap	EUR 49.8B
Next earnings date	2027-02-25
Price	EUR 799.00
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	vie/ARGX
Website	https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	33.67x
Earnings yield	3.18%
EV/Earnings	27.4x
EV/EBIT	27.4x
EV/EBITDA	27.08x
EV/FCF	52.13x
EV/Sales	8.7x
FCF / EV yield	1.92%
FCF yield	1.74%
Forward P/E	25.79x
Graham number	266.28568
Graham upside	-66.67%
P/(FCF - SBC) ratio	77.68x
P/(OCF - SBC) ratio	77.23x
P/B ratio	6.72x
P/E ratio	31.42x
P/FCF ratio	57.33x
P/OCF ratio	57.09x
P/S ratio	9.56x
Price / tangible book value	6.94x
Price/EBITDA ratio	29.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.94%
EBITDA margin	32.14%
Effective tax rate	1.14%
FCF margin	18.25%
Gross margin	59.84%
Operating margin	31.94%
Pretax margin	32.1%
Profit margin	31.73%
Profit per employee	EUR 887,234
Profitable quarters	5
Profitable years	2
Revenue per employee	EUR 2.8M
ROA	11.63%
ROA (5Y)	-4.42%
ROCE	18.94%
ROE	23.64%
ROE (5Y)	-3.39%
ROIC	56.96%
SBC / revenue	4.78%
Tax / revenue	0.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	24.08%
EPS growth (Q)	50.58%
EPS growth (QoQ)	6.85%
EPS growth quarters	7
EPS growth years	3
FCF growth	143.78%
Gross profit growth	75.23%
Gross profit growth (Q)	57.81%
Gross profit growth 3Y	146.42%
Net income growth	22.42%
Net income growth (Q)	46.98%
Net income growth (QoQ)	7.2%
Net income growth years	3
OCF growth	141.19%
OCF growth 10Y	51.21%
Operating income growth	137.21%
Operating income growth (Q)	81.44%
Revenue growth	60.6%
Revenue growth (Q)	52.08%
Revenue growth (QoQ)	13.63%
Revenue growth 10Y	79.47%
Revenue growth 3Y	79.16%
Revenue growth 5Y	63.26%
Revenue growth quarters	10
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.7M
Depreciation and amortization	EUR 10.3M
EBIT	EUR 1.7B
EBITDA	EUR 1.7B
EPS	EUR 25.43
Financing cash flow	EUR 236.5M
Free cash flow	EUR 868.9M
Free cash flow minus SBC	EUR 641.3M
Gross profit	EUR 3.1B
Income taxes	EUR 19M
Investing cash flow	EUR 236.5M
Net borrowing	EUR -9.1M
Net cash flow	EUR 1.3B
Net income	EUR 1.7B
Operating cash flow minus SBC	EUR 645.1M
Operating income	EUR 1.7B
Revenue	EUR 5.2B
Stock-based compensation	EUR 227.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 118.52
Debt / EBITDA	0.02
Debt / equity	0.01
Debt / FCF	0.05
Interest coverage	595.15
Net cash (debt)	EUR 4.5B
Net cash / market cap	9.08%
Net cash growth	32.23%
Net debt / EBITDA	-2.7
Net debt / equity	-0.61
Net debt / FCF	-5.21
Piotroski F-Score	5
Shareholders' equity	EUR 7.4B
Tangible book value	EUR 7.2B
Tangible book value per share	EUR 114.77
Total cash	EUR 4.6B
Total debt	EUR 41.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current ratio	5.12
Inventory turnover	6.12
Quick ratio	4.52
Working capital	EUR 5.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.31%
Shareholder yield	1.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 765.85
1D price change	2.86%
1M price change	-5.4%
1M total return	-5.4%
1W price change	6.25%
1W total return	6.25%
1Y price change	13.21%
1Y return CAGR	13.22%
1Y total return	13.21%
20-day SMA	EUR 778.36
200-day SMA	EUR 741.66
3M price change	1.45%
3M total return	1.45%
3Y price change	70.62%
3Y return CAGR	19.49%
3Y total return	70.62%
50-day SMA	EUR 834.55
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 918.80
52-week high date	2026-09-03
52-week low	EUR 570.80
52-week low date	2026-03-23
5Y price change	233.06%
5Y return CAGR	27.21%
5Y total return	233.06%
6M price change	20.19%
6M total return	20.19%
All-time high	EUR 918.80
All-time high date	2026-09-03
All-time low	EUR 204.20
All-time low date	2020-09-17
Average true range (ATR)	EUR 19.30
Average volume	12.3
Change from 52-week high	-13.04%
Change from 52-week low	39.98%
Change from all-time high	-13.04%
Change from all-time low	291.28%
Change from open	0.91%
Day's gap	1.93%
High price	EUR 799.00
Low price	EUR 788.00
Monthly RSI	61
Open price	EUR 791.80
Position in 52-week range	100%
Previous close	EUR 776.80
Price vs 150-day SMA	4.33%
Price vs 20-day SMA	2.65%
Price vs 200-day SMA	7.73%
Price vs 50-day SMA	-4.26%
Relative volume	9.47
RSI	51.93
Sharpe ratio	0.38
Sharpe ratio (3Y)	0.58
Sharpe ratio (5Y)	0.69
Sortino ratio	0.68
Sortino ratio (3Y)	0.96
Sortino ratio (5Y)	1.23
Weekly RSI	52.1
YTD price change	11.66%
YTD total return	11.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62.4M
Shares change (QoQ)	0.56%
Shares change (YoY)	-1.31%
Shares held by insiders	0.17%
Shares held by institutions	75.76%

Deeper analysis on VIE/ARGX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ARGX report

Is a complete VIE/ARGX research report available?

No complete published report is available for vie/ARGX (VIE/ARGX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ARGX (VIE/ARGX)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ARGX

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/ARGX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ARGX

Frequently asked questions